GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first isolated from human plasma in the 1970s by biochemist Loren Pickart. With search interest surging over 1,000% year-over-year, it has become one of the most actively researched peptides in regenerative science. Here's what makes it so compelling.
GHK-Cu is a tripeptide (three amino acids: glycine, histidine, lysine) that naturally binds copper(II) ions with high affinity. It is found in human plasma, saliva, and urine, with concentrations declining significantly with age - from approximately 200 ng/mL in plasma at age 20 to roughly 80 ng/mL by age 60.
This age-related decline, combined with the peptide's broad biological activity, has made it a central subject in aging and regenerative research.
Molecular profile: GHK-Cu has a molecular weight of 403.9 Da, making it one of the smallest bioactive peptides studied. Its compact size allows efficient tissue penetration and cellular uptake.
Unlike most peptides that act through a single receptor pathway, GHK-Cu exerts its effects primarily through gene expression modulation. A landmark 2012 study by Pickart et al. using the Broad Institute's Connectivity Map (cMap) database identified that GHK-Cu influences the expression of 4,382 genes - roughly 6% of the human genome.
GHK-Cu's most established research area is wound healing. Studies dating back to the 1980s demonstrated accelerated wound closure, increased angiogenesis, and enhanced granulation tissue formation in animal models. The peptide appears to coordinate the wound healing cascade - attracting immune cells, promoting fibroblast proliferation, stimulating collagen deposition, and eventually supporting remodelling.
Multiple controlled studies have shown GHK-Cu increases skin thickness, reduces fine lines, improves elasticity, and enhances overall skin density when applied topically. A notable study by Leyden et al. found that GHK-Cu cream applied for 12 weeks produced measurable increases in collagen synthesis compared to controls.
GHK-Cu has been shown to enlarge hair follicle size and stimulate hair growth in animal models. It appears to extend the anagen (growth) phase of the hair cycle while increasing follicular blood supply through VEGF stimulation.
Emerging research explores GHK-Cu's potential neuroprotective effects. Its ability to upregulate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) genes, combined with its anti-inflammatory and antioxidant properties, has generated interest in neurodegeneration research.
A 2010 study in Genome Medicine analyzed gene expression data from COPD patients and found that GHK-Cu could theoretically reverse many of the pathological gene expression patterns associated with emphysematous lung destruction. This remains an active area of investigation.
Several factors explain GHK-Cu's explosive growth in research attention:
GHK-Cu is typically studied via:
The reconstituted solution should be stored at 2-8°C and used within 30 days. See our reconstitution guide for preparation instructions, and review the storage guide for temperature and light-exposure best practices. Use the reconstitution calculator to confirm volumes before drawing. Always verify batch purity by reading the COA.
What is GHK-Cu?
GHK-Cu is a naturally occurring tripeptide (glycine-histidine-lysine) bound to copper(II) ions. Found in human plasma, saliva, and urine, its concentrations decline with age. Research shows it influences over 4,000 genes.
Why is GHK-Cu research interest growing?
Search interest has surged over 1,000% YoY due to genomic data showing it affects 4,382 genes, convergence with ageing research, a well-documented safety profile, and versatility across dermatology, wound healing, and neuroscience.
How is GHK-Cu administered in research?
Typically via subcutaneous injection (1–4 mg daily), topical application (1–2% solution), or iontophoresis. The reconstituted solution should be stored at 2–8°C.
New-U Peptides stocks GHK-Cu in 10-vial packs, independently verified by Janoshik and Freedom Diagnostics.
View GHK-Cu